Posted on

Athersys, Inc. is a developing biopharmaceutical company engaged in the discovery and development of therapeutics. MultiStem is a patented and proprietary stem cell treatment for multiple disease indications, and that is currently being evaluated in two ongoing clinical trials. In addition, Athersys is developing novel pharmaceuticals to treat indications such as obesity, certain cognitive and attention disorders, narcolepsy or other forms of excessive daytime sleepiness, bone marrow transplant and stroke.